Showing results (51-60 of 182) with videos related to
Sort By:
Pageof 19
Chest|November 24, 2005
Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancerNithya Ramnath, Eric Sommers, Lary Robinson, et al.Plos One|March 14, 2013
A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacyJun Zhou, Zhengming Chen, Agnes Malysa, et al.Cancer Biology & Therapy|July 28, 2009
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cellsJingchun Gao, Zhong Zheng, Bhupendra Rawal, et al.Journal of Cellular Physiology|June 29, 2018
RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancerMay Chammaa, Agnes Malysa, Carlos Redondo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Enzastaurin, an oral serine/threonine kinase inhibitor, as second- or third-line therapy of non-small-cell lung cancerYun Oh, Roy S Herbst, Howard Burris, et al.BJU International|May 5, 2010
Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patientsLauren C Harshman, Gerold Bepler, Zhong Zheng, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2010
Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancersTawee Tanvetyanon, Lary Robinson, K Eric Sommers, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 6, 2010
Parameters for individualizing systemic therapy in non-small cell lung cancerShirish M Gadgeel, Michele L Cote, Ann G Schwartz, et al.Archives of Internal Medicine|March 26, 2008
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006Benjamin Djulbegovic, Ambuj Kumar, Heloisa P Soares, et al.Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
Prognostic significance of gelsolin expression level and variability in non-small cell lung cancerJun Yang, Dongfeng Tan, Harold L Asch, et al.Pageof 19